Mounjaro targets two hormones in the incretin class, GLP-1 and GIP. In the US, Lilly markets the obesity version of the drug under the brand name Zepbound.
Attribution
This digest is published with acknowledgment to Business Today. For the complete analysis, headnotes, and citations, please refer to the source.
Read on Business Today
I get asked this a lot, so let me answer it properly. Continue reading on Medium »
Medium — Accounting · shmdigi
The small errors that quietly drain cash, trigger penalties, and make tax season painful — and how to fix them. Continue reading on Medium »
Medium — Accounting · Mubashir Rao
Romeo Whiskey Tango, continued. Continue reading on Medium »
Medium — Tax & Accounting · Chris Maley
Every few months, another headline tells accountants their job is over. AI can reconcile accounts. AI can file taxes. AI can audit a… Continue reading on Medium »
Medium — Accounting · Chinwe O.
